Dexmedetomidine: A novel analgesic with palliative medicine potential

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 20, Issue 2, 2006, Pages 23-27

  Jackson II, Kenneth C ^a,d   Wohlt, Paul ^b   Fine, Perry G ^a,c  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b University of Wisconsin Health   (United States)

^c National Hospice and Palliative Care Organization   (United States)

^d Pharmacotherapy Outcomes Research Center   (United States)

Author keywords

Analgesic; Dexmedetomidine; Palliative care

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; AMPHETAMINE DERIVATIVE; ANALGESIC AGENT; ATIPAMEZOLE; ATROPINE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; CODEINE; DEXMEDETOMIDINE; DEXTROMETHORPHAN; FLUOXETINE; HYDROCODONE; ISONIAZID; LIDOCAINE; METHOXSALEN; MICONAZOLE; MIRTAZAPINE; NEFAZODONE; OPIATE DERIVATIVE; OXYCODONE; PAROXETINE; PROPOFOL; RISPERIDONE; RITONAVIR; THIORIDAZINE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANESTHESIA; ARTICLE; BRADYCARDIA; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG SAFETY; HEART ATRIUM FIBRILLATION; HOSPICE CARE; HUMAN; HYPERTENSION; HYPOTENSION; INTENSIVE CARE; NAUSEA; PALLIATIVE THERAPY; SEDATION; SYMPTOMATOLOGY; XEROSTOMIA;

ANALGESICS, NON-NARCOTIC; CLINICAL TRIALS; DEXMEDETOMIDINE; DRUG INTERACTIONS; HUMANS; PALLIATIVE CARE;

EID: 33745481071     PISSN: 15360288     EISSN: 15360539     Source Type: Journal    
DOI: 10.1300/J354v20n02_05     Document Type: Article

References (19)

1. Precedex® (dexmedetomidine) package insert. Lake Forest, IL: Hospira, Inc., April 2004.
2. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine Drugs. 2000 Feb;59(2):263-8.
3. Aho MS, Erkola OA, Scheinin H, Lehtinen AM, Korttila KT. Effect of intravenously administered dexmedetomidine on pain after laparoscopic tubal ligation. AnesthAnalg. 1991 Aug;73(2):112-8.
4. Jaakola ML, Salonen M, Lehtinen R, Scheinin H. The analgesic action of dexmedetomidine - a novel alpha 2-adrenoceptor agonist-in healthy volunteers. Pain. 1991 Sep;46(3):281-5.
5. Peden CJ, Prys-Roberts C. Dexmedetomidine-a powerful new adjunct to anaesthesia? Br J Anaesth. 1992 Feb;68(2):123-5.
6. Kallio A, Scheinin M, Koulu M, Ponkilainen R, Ruskoaho H, Viinamaki O, Scheinin H. Effects of dex-medetomidine, a selective alpha 2-adrenoceptor agonist, on hemodynamic control mechanisms. Clin Pharmacol Ther. 1989 Jul;46(1):33-42.
7. Scheinin B, Lindgren L, Randell T, Scheinin H, Scheinin M. Dexmedetomidine attenuates sympatho-adrenal responses to tracheal intubation and reduces the need for thiopentone and peroperative fentanyl. Br J Anaesth. 1992 Feb:68(2):126-31.
8. Erkola O, Korttila K, Aho M, Haasio J, Aantaa R, Kallio A. Comparison of intramuscular exmedetomidine and midazolam premedication for elective abdominal hysterectomy. Anesth Analg. 1994 Oct;79(4):646-53.
9. Dyck JB, Maze M, Haack C, Vuorilehto L, Shafer SL. The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology. 1993 May;78(5):813-20.
10. Kivisto KT, Kallio A. Neuvonen PJ. Pharmacokinetics and pharmacodynamics of transdermal dex-medetomidine. Eur J Clin Pharmacol. 1994;46(4):345-9.
11. De Wolf AM, Fragen RJ, Avram MJ. Fitzgerald PC, Rahimi-Danesh F. The pharmacokinetics of dex-medetomidine in volunteers with severe renal impairment. Anesth Analg. 2001 Nov;93(5):1205-9.
12. Karhuvaara S, Kallio A, Salonen M, Tuominen J. Scheinin M. Rapid reversal of alpha 2-adrenoceptor agonist effects by atipamezole in human volunteers. Br J Clin Pharmacol. 1991 Feb;31(2):160-5.
13. Arain SR, Ruehlow RM, Uhrich TD, Ebert TJ. The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesth Analg. 2004 Jan;98(1):153-8.
14. Alhashemi JA, Kaki AM. Dexmedetomidine in combination with morphine PCA provides superior analgesia for shockwave lithotripsy. Can J Anaesth. 2004 Apr;51(4):342-7.
15. Cortinez LI, Hsu YW, Sum-Ping ST, Young C, Keifer JC, Macleod D, Robertson KM, Wright DR, Moretti EW. Somma J. Dexmedetomidine pharmacodynamics: Part II: Crossover comparison of the analgesic effect of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology. 2004 Nov; 101(5):1077-83.
16. Talke P, Chen R, Thomas B, Aggarwall A, Gottlieb A, Thorborg P, Heard S, Cheung A, Son SL, Kallio A. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg. 2000 Apr;90(4):834-9.
17. Khasawinah TA, Ramirez A, Berkenbosch JW, Tobias JD. Preliminary experience with dexmedetomidine in the treatment of cyclic vomiting syndrome. Am J Ther. 2003 Jul-Aug; 10(4):303-7.
18. Memis D, Turan A, Karamanlioglu B, Pamukcu Z, Kurt I. Adding dexmedetomidine to lidocaine for intravenous regional anesthesia. Anesth Analg. 2004 Mar; 98(3):835-40.
19. Soares LG, Naylor C, Martins MA, Peixoto G. Dexmedetomidine: a new option for intractable distress in the dying. J Pain Symptom Manage. 2002 Jul:24(1): 6-8.